<< Back to News

System Formulary Update
Rituximab-pvvr (Ruxience)

Situation

Rituximab-pvvr (Ruxience) 10 mg/mL (10 mL SDV) and 10 mg/mL (50 mL SDV) for injection was approved for addition to the health system formulary at the December 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Rituximab-pvvr (Ruxience) 10 mg/mL (10 mL SDV) and 10 mg/mL (50 mL SDV) for injection

Assessment/Recommendation

Change effective: Tuesday, February 1^st

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Rituximab-pvvr (Ruxience) 10 mg/mL (10 mL SDV) for injection
• Rituximab-pvvr (Ruxience) 10 mg/mL (50 mL SDV) for injection

Note: Stock of this formulary product may vary at individual entities